Report Detail
Global Coagulation Factor XI Market Insights, Forecast to 2025
- RnM2983562 |
- 19 February, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
The global Coagulation Factor XI market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Coagulation Factor XI market based on company, product type, end user and key regions.
This report studies the global market size of Coagulation Factor XI in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Coagulation Factor XI in these regions.
This research report categorizes the global Coagulation Factor XI market by top players/brands, region, type and end user. This report also studies the global Coagulation Factor XI market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer AG
Bristol-Myers Squibb Company
Cambryn Biologics LLC
eXithera Pharmaceuticals, Inc
Ionis Pharmaceuticals, Inc.
LegoChem Biosciences, Inc
Market size by Product
MR-1007
IONIS-FXIRx
EP-7041
AB-022
BMS-262084
Others
Market size by End User
Thrombosis
Bleeding and Clotting Disorders
Acute Ischemic Stroke
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Coagulation Factor XI market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Coagulation Factor XI market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Coagulation Factor XI companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Coagulation Factor XI submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Coagulation Factor XI are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Coagulation Factor XI market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Coagulation Factor XI Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Coagulation Factor XI Market Size Growth Rate by Product
- 1.4.2 MR-1007
- 1.4.3 IONIS-FXIRx
- 1.4.4 EP-7041
- 1.4.5 AB-022
- 1.4.6 BMS-262084
- 1.4.7 Others
- 1.5 Market by End User
- 1.5.1 Global Coagulation Factor XI Market Size Growth Rate by End User
- 1.5.2 Thrombosis
- 1.5.3 Bleeding and Clotting Disorders
- 1.5.4 Acute Ischemic Stroke
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Coagulation Factor XI Market Size
- 2.1.1 Global Coagulation Factor XI Revenue 2014-2025
- 2.1.2 Global Coagulation Factor XI Sales 2014-2025
- 2.2 Coagulation Factor XI Growth Rate by Regions
- 2.2.1 Global Coagulation Factor XI Sales by Regions
- 2.2.2 Global Coagulation Factor XI Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Coagulation Factor XI Sales by Manufacturers
- 3.1.1 Coagulation Factor XI Sales by Manufacturers
- 3.1.2 Coagulation Factor XI Sales Market Share by Manufacturers
- 3.1.3 Global Coagulation Factor XI Market Concentration Ratio (CR5 and HHI)
- 3.2 Coagulation Factor XI Revenue by Manufacturers
- 3.2.1 Coagulation Factor XI Revenue by Manufacturers (2014-2019)
- 3.2.2 Coagulation Factor XI Revenue Share by Manufacturers (2014-2019)
- 3.3 Coagulation Factor XI Price by Manufacturers
- 3.4 Coagulation Factor XI Manufacturing Base Distribution, Product Types
- 3.4.1 Coagulation Factor XI Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Coagulation Factor XI Product Type
- 3.4.3 Date of International Manufacturers Enter into Coagulation Factor XI Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Coagulation Factor XI Sales by Product
- 4.2 Global Coagulation Factor XI Revenue by Product
- 4.3 Coagulation Factor XI Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Coagulation Factor XI Breakdown Data by End User
6 North America
- 6.1 North America Coagulation Factor XI by Countries
- 6.1.1 North America Coagulation Factor XI Sales by Countries
- 6.1.2 North America Coagulation Factor XI Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Coagulation Factor XI by Product
- 6.3 North America Coagulation Factor XI by End User
7 Europe
- 7.1 Europe Coagulation Factor XI by Countries
- 7.1.1 Europe Coagulation Factor XI Sales by Countries
- 7.1.2 Europe Coagulation Factor XI Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Coagulation Factor XI by Product
- 7.3 Europe Coagulation Factor XI by End User
8 Asia Pacific
- 8.1 Asia Pacific Coagulation Factor XI by Countries
- 8.1.1 Asia Pacific Coagulation Factor XI Sales by Countries
- 8.1.2 Asia Pacific Coagulation Factor XI Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Coagulation Factor XI by Product
- 8.3 Asia Pacific Coagulation Factor XI by End User
9 Central & South America
- 9.1 Central & South America Coagulation Factor XI by Countries
- 9.1.1 Central & South America Coagulation Factor XI Sales by Countries
- 9.1.2 Central & South America Coagulation Factor XI Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Coagulation Factor XI by Product
- 9.3 Central & South America Coagulation Factor XI by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Coagulation Factor XI by Countries
- 10.1.1 Middle East and Africa Coagulation Factor XI Sales by Countries
- 10.1.2 Middle East and Africa Coagulation Factor XI Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Coagulation Factor XI by Product
- 10.3 Middle East and Africa Coagulation Factor XI by End User
11 Company Profiles
- 11.1 Bayer AG
- 11.1.1 Bayer AG Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Bayer AG Coagulation Factor XI Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Bayer AG Coagulation Factor XI Products Offered
- 11.1.5 Bayer AG Recent Development
- 11.2 Bristol-Myers Squibb Company
- 11.2.1 Bristol-Myers Squibb Company Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Bristol-Myers Squibb Company Coagulation Factor XI Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Bristol-Myers Squibb Company Coagulation Factor XI Products Offered
- 11.2.5 Bristol-Myers Squibb Company Recent Development
- 11.3 Cambryn Biologics LLC
- 11.3.1 Cambryn Biologics LLC Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Cambryn Biologics LLC Coagulation Factor XI Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Cambryn Biologics LLC Coagulation Factor XI Products Offered
- 11.3.5 Cambryn Biologics LLC Recent Development
- 11.4 eXithera Pharmaceuticals, Inc
- 11.4.1 eXithera Pharmaceuticals, Inc Company Details
- 11.4.2 Company Business Overview
- 11.4.3 eXithera Pharmaceuticals, Inc Coagulation Factor XI Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 eXithera Pharmaceuticals, Inc Coagulation Factor XI Products Offered
- 11.4.5 eXithera Pharmaceuticals, Inc Recent Development
- 11.5 Ionis Pharmaceuticals, Inc.
- 11.5.1 Ionis Pharmaceuticals, Inc. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Ionis Pharmaceuticals, Inc. Coagulation Factor XI Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Ionis Pharmaceuticals, Inc. Coagulation Factor XI Products Offered
- 11.5.5 Ionis Pharmaceuticals, Inc. Recent Development
- 11.6 LegoChem Biosciences, Inc
- 11.6.1 LegoChem Biosciences, Inc Company Details
- 11.6.2 Company Business Overview
- 11.6.3 LegoChem Biosciences, Inc Coagulation Factor XI Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 LegoChem Biosciences, Inc Coagulation Factor XI Products Offered
- 11.6.5 LegoChem Biosciences, Inc Recent Development
12 Future Forecast
- 12.1 Coagulation Factor XI Market Forecast by Regions
- 12.1.1 Global Coagulation Factor XI Sales Forecast by Regions 2019-2025
- 12.1.2 Global Coagulation Factor XI Revenue Forecast by Regions 2019-2025
- 12.2 Coagulation Factor XI Market Forecast by Product
- 12.2.1 Global Coagulation Factor XI Sales Forecast by Product 2019-2025
- 12.2.2 Global Coagulation Factor XI Revenue Forecast by Product 2019-2025
- 12.3 Coagulation Factor XI Market Forecast by End User
- 12.4 North America Coagulation Factor XI Forecast
- 12.5 Europe Coagulation Factor XI Forecast
- 12.6 Asia Pacific Coagulation Factor XI Forecast
- 12.7 Central & South America Coagulation Factor XI Forecast
- 12.8 Middle East and Africa Coagulation Factor XI Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Coagulation Factor XI Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Coagulation Factor XI . Industry analysis & Market Report on Coagulation Factor XI is a syndicated market report, published as Global Coagulation Factor XI Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Coagulation Factor XI market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
